OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.

Biotechnology

OncoSenX

OncoSenX's headquarters in Seattle, WA, United States

Matthew Scholz

Stephen Hilbert

Eric Garcia

John D. Lewis

Gary C. Hudson

OncoSenX's Leadership Team includes Hank Garcia and 5 others.

Leadership Team

This department provides strategic direction and governance for the organization.

Executive Leadership

This department provides expert guidance and insights on scientific research and innovation initiatives.

OncoSenX

Org chart

Board & advisors

Teams

Leadership Team

Executive Leadership

Scientific Advisory

Offices

OncoSenX

Org chart

Board & advisors

Teams

Leadership Team

Executive Leadership

Scientific Advisory

Offices

Related companies